Health Systems Strengthening Project Impact Evaluation 2015, Baseline Survey
Liberia, 2013 - 2015
Get Microdata
Reference ID
LBR_2015_HRBFIE-BL_v01_M
Producer(s)
Kenneth Leonard (University of Maryland), Luke Bawo, Rianna Mohammed-Roberts
Collection(s)
Metadata
Created on
Jan 13, 2020
Last modified
Jan 13, 2020
Page views
210024
Downloads
209
Q106: I. Other (specify) (q106i_specify)
Data file: p_v_4
Overview
Valid:
32
Invalid:
0
Type:
Discrete
Start:
918
End:
967
Width:
50
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ACT | 4 |
12.5%
|
|
| ACT,PCM,DEWORM(VERMOX) | 1 |
3.1%
|
|
| AMPICI IV,CEFTRIAXINE,ANTIPYRETIC,COUGH SYRUP | 1 |
3.1%
|
|
| AMPICILIN | 1 |
3.1%
|
|
| AMPICILIN IV | 2 |
6.3%
|
|
| AMPICILLIN | 2 |
6.3%
|
|
| AMPICILLIN IV | 1 |
3.1%
|
|
| AMPICILLINE IV,ACT | 1 |
3.1%
|
|
| AMPLICILIN IV | 1 |
3.1%
|
|
| ANALGEAS,THROMYCIN | 1 |
3.1%
|
|
| ANTIPYRETIC,COUGH SYRUP,ACT | 1 |
3.1%
|
|
| COUGH EXPECTORANT | 2 |
6.3%
|
|
| DEWORMING | 1 |
3.1%
|
|
| IV-ANTIBIOTIC AMP AND GENT | 1 |
3.1%
|
|
| M-VIT, FERROUS SULFATE | 1 |
3.1%
|
|
| MEBENDAZOLE | 1 |
3.1%
|
|
| PCM | 3 |
9.4%
|
|
| PCM 500MG | 1 |
3.1%
|
|
| PCM, FEFA | 1 |
3.1%
|
|
| PERACETEMOL | 1 |
3.1%
|
|
| PERACETIMOL | 1 |
3.1%
|
|
| REFERRAL | 1 |
3.1%
|
|
| VERMOX | 1 |
3.1%
|
|
| VERMOX, M-VIT, FEFA | 1 |
3.1%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.